Erika Jones
Fortuna: 189 033 $ al 31/05/2026
Fortuna: 189 033 $ al 31/05/2026
Erika Jones currently works at Black Diamond Therapeutics, Inc., as Chief Financial & Accounting Officer from 2024.
Ms. Jones also formerly worked at Axcella Health, Inc., as Finance Director from 2016 to 2019 and Ernst & Young LLP, as Manager-Advisory Services from 2008 to 2015.
Ms. Jones received her undergraduate degree and graduate degree from Miami University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/01/2026 | 85.150 ( 0,15 % ) | 189 033 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director Financiero/CFO | 07/10/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| AXCA HEALPAR | Director Financiero/CFO | 01/10/2019 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/02/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.